N
NanoCellect Biomedical
A critical element for biomedical research is the ability to analyze and isolate cells using flow cytometers
About NanoCellect Biomedical
NanoCellect Biomedical Inc. is a life sciences company focused on developing and commercializing advanced cell sorting technologies. The company was founded in 2009 by José Morachis, Will Alaynick, and Sung Hwan Cho. The founders' collective expertise in engineering, molecular biology, and business from their time at the University of California, San Diego, provided the foundation for the company's core technology. Their journey began with the recognition of a significant unmet need in the research community for a gentler, more accessible, and affordable cell sorter that could handle sensitive cells without causing damage.
The company operates in the cell analysis market, serving researchers in academic institutions, biotechnology, and pharmaceutical companies. Its business model revolves around the sale of its proprietary instruments, consumables, and software. Revenue is generated through the direct sale of these products and recurring income from the single-use microfluidic cartridges required for the system's operation.
NanoCellect's flagship product is the WOLF Cell Sorter, which utilizes a microfluidic-based, sterile, and disposable cartridge system. This design distinguishes it from traditional fluorescence-activated cell sorters (FACS) by providing a gentle sorting mechanism that minimizes stress on cells, thereby improving cell viability and preserving their integrity. The WOLF is a benchtop instrument known for its ease of use, requiring minimal training to operate. It is capable of sorting and dispensing single cells into 96-well or 384-well plates, making it particularly suitable for applications such as single-cell genomics, antibody discovery, and cell line development. The system avoids the complex fluidics and high pressures of traditional sorters, eliminating the need for dedicated operators and extensive cleanup procedures. Another key product, the N1 Single-Cell Dispenser, complements the WOLF by enabling precise dispensing of single cells for downstream analysis.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- San Diego, United States
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 62.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Accounting, Testing, Verification, Biotechnology, Spinout, Biotech and Pharma, medical testing, DT and LS, science-based
- Technology
- Hardware
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jun 2023 | $29M | $116M | Undisclosed | ↗ |
| GRANTOther financing | Jan 2022 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for NanoCellect Biomedical is 10K monthly website visits, down 9.1% over the last three months. NanoCellect Biomedical's team declined 18.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Illumina Ventures
Anzu Partners
Vertical Venture Partners
Genoa Ventures
FusionX Ventures- HFHighlander Venture Fund
Series B and later5 investors entered at this stage
Yonjin Venture- AVAgilent Ventures
- SESagian Equity
Warburg Pincus
Casdin Capital
Other known investors1 additional known investor
University of California, San Diego
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NanoCellect Biomedical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NanoCellect Biomedical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







